BMJ mental healthHumansCost-Benefit AnalysisUnited KingdomTranscranial Magnetic StimulationDepressive Disorder
Is it time for mental health services to invest in neurostimulation? An economic evaluation of transcranial magnetic stimulation therapies for the treatment of moderate to severe treatment-resistant depression in the UK.
Edward Cox, Jing Ma, Cristina Roadevin, Richard Morriss, Marilyn James
Published: 202610.1136/bmjment-2025-302237
Abstract
BACKGROUND: Although transcranial magnetic stimulation (TMS) protocols are safe and efficacious therapies for treatment-resistant depression (TRD), they remain inaccessible for many people in the UK and internationally. One of the main reasons for th…
Preview only. Read the full abstract at the source